InvestorsHub Logo
Followers 2
Posts 356
Boards Moderated 0
Alias Born 06/16/2017

Re: None

Sunday, 09/24/2017 4:33:11 AM

Sunday, September 24, 2017 4:33:11 AM

Post# of 40984
There was at one point a while back issues with instrumentation required to set surgeons up for success in the past that resulted in them losing surgeons. This was well documented, however has since been resolved. After updating their instrumentation (among others things), There has been a 38% increase in surgeon users since the end of 2016. In addition, the demand for Silcone Nitride - Specifically Taurus (with modular head/helical flange design) has never been higher as expressed in the latest business update and the tech has now been backed by extensive research publications.

While the build from Alpha to Beta for Taurus has been slow and steady, They do appear to be rising month to month with increased demand and 3Q now turning out some of the highest monthly revenue year to date. It's a hint at things to come, with having to pull more units just to keep up with demand for 4q a VERY good sign. Considering revs increasing while debt decreasing (herc nearly gone) and the company seeking alternative financing methods as opposed to toxic financing is a sign of strong financial discipline to maintain operations and controls. While longs did take a beating, Their financial recovery over the last two years alone should be mentioned as pretty miraculous. With China and Japan just around the corner, SN revs growing and increased interest/demand for the tech, I don't see this company sitting on the shelf for too much longer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News